DCGI orders withdrawal of AstraZeneca's anti-cancer drug 'Olaparib tablets' for certain treatments
India | May 23, 2024 8:36 ISTThe Drug Controller General of India said that the drug may continue to be marketed for other approved indications.The communication noted that the company provided clinical evidence supporting the withdrawal of the indication for Olaparib tablets.